SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001509190-15-000023
Filing Date
2015-08-07
Accepted
2015-08-07 16:15:17
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q petx-20150630x10q.htm 10-Q 1843750
2 EX-31.1 petx-20150630xex311.htm EX-31.1 19773
3 EX-31.2 petx-20150630xex312.htm EX-31.2 20015
4 EX-32.1 petx-20150630xex321.htm EX-32.1 6842
5 EX-32.2 petx-20150630xex322.htm EX-32.2 7235
  Complete submission text file 0001509190-15-000023.txt   8456732

Data Files

Seq Description Document Type Size
6 EX-101.INS petx-20150630.xml EX-101.INS 2105457
7 EX-101.SCH petx-20150630.xsd EX-101.SCH 48017
8 EX-101.CAL petx-20150630_cal.xml EX-101.CAL 75436
9 EX-101.DEF petx-20150630_def.xml EX-101.DEF 226841
10 EX-101.LAB petx-20150630_lab.xml EX-101.LAB 398581
11 EX-101.PRE petx-20150630_pre.xml EX-101.PRE 390083
Mailing Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103
Business Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103 913.951.2130
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35952 | Film No.: 151037697
SIC: 2834 Pharmaceutical Preparations